Heart transplantation - An update

Clinical Cardiology

Volumn 19, Issue 12, 1996, Pages 930-938

  Blum, Arnon ^a   Aravot, Dan ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

cellular rejection; heart transplantation; humoral rejection

Indexed keywords

15 DEOXYSPERGUALIN; AZATHIOPRINE; CYCLOSPORIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 4; PREDNISONE; RAPAMYCIN; TACROLIMUS; VINCRISTINE;

DIFFERENTIAL DIAGNOSIS; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE IRRADIATION; ORAL DRUG ADMINISTRATION; PATIENT SELECTION; POSTOPERATIVE INFECTION; PUVA; REVIEW; SURVIVAL TIME; TREATMENT INDICATION;

EID: 0029845003     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960191206     Document Type: Review

References (51)

1. O'Connell JB, Bourge RC, Costanzo-Nordin MR, Driscoll DJ, Morgan JP, Rose EA, Uretsky BF: Cardiac transplantation: Recipient selection, donor procurement, and medical follow-up. A statement for health professionals from the Committee on Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 1992;86:1061-1079
2. Kriett JM, Kaye MP: The Registry of the International Society for Heart and Lung Transplantation. Eighth official report - 1991. J Heart Lung Transplant 1991;10:491-498
3. The CONSENSUS Trial Study Group: Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-1435
4. Keogh AM, Baron DW, Hickie JB: Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. Am J Cardiol 1990;65:903-908
5. Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkin WB, Jacobs W, Francis GS, Fiona KH, Goldman S, Cobb FR, Shah PM, Saunders R, Fletcher RD, Loeb HS, Hughes VC, Baker B: Effect of vasodilator therapy on mortality in chronic congestive heart failure: Results of Veterans' Administration Cooperative Study. N Engl J Med 1986;314:1547-1552
6. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman B, Loeb H, Wong M, Bhat G, Goldman S, Fletcher RD, Doherty J, Hughes V, Carson P, Contron G, Shabetai R, Haakenson C: A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303-310
7. O'Connell JB, Dec GW, Goldenberg IF, Starling RC, Mudge GH, Augustine SM, Constanzo-Nordin MR, Hess ML, Hosenpud JD, Icenogle TB, Menlove RL, Billingham ME: Results of heart transplantation for active lymphocytic myocarditis. J Heart Transplant 1990;9:351-356
8. Aravot DJ, Banner NR, Madden B, Aranki S, Khaghani A, Fitzgerald M, Radley-Smith R, Yacoub MH: Primary cardiac tumours - is there a place for cardiac transplantation? Eur J Cardiothorac Surg 1989;3:531-524
9. Griepp RB, Stinson EB, Dong E Jr, Clark DA, Shumway NE: Determinants of operative risk in human heart transplantation. Am J Surg 1971;122:192-197
10. Kormos RL, Thompson M, Hardesty RL, Griffith BP, Trento A, Uretsky BF, Reddy PS: Utility of preoperative right heart catheterization data as a predictor of survival after heart transplantation. J Heart Transplant 1986;5:391-393
11. Kirklin JK, Naftel DC, Kirklin JW, Blackstone EH, White-Williams C, Bourge RC: Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant 1988;7:331-336
12. Jones, K, Higenbottam T, Wallwork J: Pulmonary vasodilation with prostacyclin in primary and secondary pulmonary hypertension. Chest 1989;96:784-789
13. Munoz E, Longquist J, Radovancevic B, Baldwin RT, Ford S, Duncop JM, Frazier OH: Long-term results in diabetic patients undergoing cardiac transplantation. J Heart Transplant 1991;10: 189-190
14. Spec CH, Angermann CE, Beyer RW, Schreiner J, Lehnert P, Kemkes BM, Theisen K: Increased incidence of cholelithiasis in heart transplant recipients receiving cyclosporine therapy. J Heart Transplant 1990;9:404-407
15. Keogh A, Simons L, Spratt P, Esmore D, Chang V, Hickie J, Baron D: Hyperlipidemia after heart transplantation. J Heart Transplant 1988;7:171-175
16. Aravot DA, Banner NR, Khaghani A, Fitzgerald M, Radley-Smith R, Mitchell AG, Yacoub MH: Cardiac transplantation in the seventh decade of life. Am J Cardiol 1989;63:90-93
17. Lammermeier DE, Nakatani T, Sweeney MS, Van Buren CT, Macris MP, Duncan M, Frazier DH: Effect of prior cardiac surgery on survival after heart transplantation. Ann Thorac Surg 1989;48: 168-172
18. McGoon MD, Frantz RP: Techniques of immunosuppression after cardiac transplantation. Mayo Clin Proc 1992;67:586-595
19. Yacoub M, Festenstein H, Doyle P, Martin M, McCloskey D, Awad J, Gamba A, Khaghani A, Holmes J: The influence of HLA matching in cardiac allograft recipients receiving cyclosporine and azathioprine. Transplant Proc 1987;19:2487-2489
20. Kahan BD: Cyclosporine. N Engl J Med 1989;321:1725-1738
21. Woodley SL, Renlund DG, O'Connell JN, Bristow MR: Immunosuppression following cardiac transplantation. Cardiol Clin 1990; 8:83-96
22. Cosimi AB: Antilymphocyte globulin and monoclonal antibodies. In Kidney Transplantation: Principles and Practice, (Ed. Morris PJ) 3rd Ed, p. 343-369. Philadelphia: W.B. Saunders Co., 1988
23. Todd PA, Brogden RN: Muromonab CD3: A review of its pharmacology and therapeutic potential. Drugs 1989;37:871-899
24. Bach J-F, Chatenoud L: Immunologic monitoring of Orthoclone OKT3-treated patients: The problem of antimonoclonal immune response. Transplant Proc 1987;19(suppl 1):17-20
25. Levin B, Bohannon L, Warvariv V, Bry W, Collins G: Total lymphoid irradiation (TLI) in the cyclosporine era: Use of TLI in resistant cardiac allograft rejection. Transplant Proc 1989;21:1793-1795
26. Morris RE, Hoyt EG, Murphy MP, Shorthouse R: Immunopharmacology of FK-506. Transplant Proc 1989;21:1042-1044
27. Olsen SL, O'Connell JB, Bristow MR, Renlund DG: Methotrexate as an adjunct in the treatment of persistent mild cardiac allograft rejection. Transplantation 1990;50:773-775
28. Crandall BG, Gilbert EM, Renlund DG, Menlove RL, Herrick CM, Holland CS, Hagan ME, Rasmussen LG, Karwande SV, O'Connell JB, Bristow MR: A randomized trial of the immunosuppressive efficacy of vincristine in cardiac transplantation. Transplantation 1990;50:34-38
29. O'Connell JB, Bristow MR, Rasmussen LG, Ratkovec RM, Gay WA, Jones KW, Renlund DG: Cardiac allograft function with corticosteroid-free maintenance immunosuppression. Circulation 1990;82(suppl 4):IV318-IV321
30. Olson LJ, Rodeheffer RJ: Management of patients after cardiac transplantation. Mayo Clin Proc 1992;67:775-784
31. Valantine HA, Yeoh TK, Gibbons R, McCarthy P, Stinson EB, Billingham ME, Popp RL: Sensitivity and specificity of diastolic indexes for rejection surveillance: Temporal correlation with endomyocardial biopsy. J Heart Lung Transplant 1991;10:757-765
32. Hammond EH, Yowell RL, Nunoda S, Menlove RL, Renlund DG, Bristow MR: Vascular (humoral) rejection in heart transplantation: Pathologic observations and clinical implications. J Heart Transplant 1989;8:430-443
33. Imakita M, Tazelaar HD, Billingham ME: Heart allograft rejection under varying immunosuppressive protocols as evaluated by endomyocardial biopsy. J Heart Transplant 1986;5:279-285
34. Gao SZ, Schroeder JS, Hunt S, Stinson EB: Retransplantation for severe accelerated coronary artery disease in heart transplant recipients. Am J Cardiol 1988;62:876-881
35. Johnson DE, Gao SZ, Schroeder JS, Hunt S, Alderman EL, Stinson E: The spectrum of coronary artery pathologic findings in human cardiac allografts. J Heart Transplant 1989;8:349-359
36. Stinson EB: Progressive coronary luminal narrowing after cardiac transplantation. Circulation 1990;82(suppl 4):IV269-IV275
37. Gao SZ, Alderman EL, Schroeder JS, Silverman JF, Hunt SA: Accelerated coronary vascular disease in the heart transplant patient: Coronary arteriographic findings. J Am Coll Cardiol 1988; 12:334-340
38. St. Goar FG, Pinto FJ, Alderman El, Valantine HA, Schroeder JS, Gao SZ, Stinson EB, Popp RL: Intracoronary ultrasound in cardiac transplant recipients: In vivo evidence of "angiographically silent" intimai thickening. Circulation 1992;85:979-987
39. Gao SZ, Schroeder JS, Alderman EL, Hunt SA, Silverman JF, Weiderhold V, Stinson EB: Clinical and laboratory correlates of accelerated coronary artery disease in the cardiac transplant patient. Circulation 1987;76(suppl 5):V56-V61
40. Mullins PA, Shapiro LM, Aravot DA, Mitchell AG, Yacoub M: Experience of percutaneous transluminal coronary angioplasty in orthotopic cardiac transplant recipients. Eur Heart J 1991;12: 1205-1207
41. Schroeder JS, Gao SZ, Alderman El, Alderman EL, Hunt S, Stinson E: Diltiazem inhibits development of early accelerated transplant coronary disease - an interim report (abstr). Circulation 1990;82(suppl 3):III-257
42. Valantine HA, Appleton CP, Halle KL, Hunt SA, Billingham ME, Shumway NE, Stinson EB, Popp RL: A hemodynamic and Doppler echocardiographic study of ventricular function in long-term cardiac allograft recipients: Etiology and prognosis of restrictive-constrictive physiology. Circulation 1989;79:66-75
43. Scherrer U, Vissing SF, Morgan BJ, Rollins JA, Tindall RSA, Ring S, Hanson P, Mohanty PK, Victor RG: Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 1990;323:693-699
44. Greenberg A, Egel JW, Thompson ME, Hardesty RL, Griffith BP, Bahnson HT, Bernstein RL, Hastillo A, Hess ML, Puschett JB: Early and late forms of cyclosporine nephrotoxicity: Studies in cardiac transplant recipients. Am J Kidney Dis 1987;9:12-22
45. Taylor DO, Thompson JA, Hastillo A, Barnhart G, Rider S, Lower RR, Hess ML: Hyperlipidemia after clinical heart transplantation. J Heart Transplant 1989;8:209-213
46. Kuo PC, Kirshenbaum JM, Gordon J, Laffel G, Young P, DiSesa VJ, Mudge GH, Vaughan DE: Lovastatin therapy for hypercholesterolemia in cardiac transplant recipients. Am J Cardiol 1989;64: 631-635
47. Ballantyne CM, Radovancevic B, Farmer JA, Frazier OH, Chandler L, Payton-Ross CH, Cocanougher B, Jones PH, Young JB, Gotto AM: Hyperlipidemia after heart transplantation: Report of a 6-year experience, with treatment recommendations. J Am Coll Cardiol 1992;19:1315-1321
48. Rhenman MJ, Rhenman B, Icenogle T: Diabetes and heart transplantation. J Heart Transplant 1988;7:356-358
49. Penn I: Why do immunosuppressed patients develop cancer. Crit Rev Oncol 1989;1:27-52
50. Nalesnik MA, Jaffe R, Starzl Te: The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988; 133:173-192
51. Graver JM, Connoly MW: The percutaneous intraaortic balloon pump and ventricular assist devices. In Hurst's The Heart, 8th Ed. (Eds. Schlant RC and Alexander RW), p. 621-627. New York: McGraw-Hill, Inc., 1995